Despite the low incidence of penile cancer nowadays, this tumor presents a difficult diagnosis and staging methodology as well as difficult therapeutic options. The author emphasises the clear destruction between superficial and invasive neoplasms. In the latter, the simultaneous treatment of the lymphatic territories is considered of extreme importance.Despite the low incidence of penile cancer nowadays, this tumor presents a difficult diagnosis and staging methodology as well as difficult therapeutic options. The author emphasises the clear destruction between superficial and invasive neoplasms. In the latter, the simultaneous treatment of the lymphatic territories is considered of extreme importance
Abstract: The majority of penile carcinoma is squamous cell carcinoma. Although uncommon in the Unit...
The penile carcinoma is rare neoplasia representing 1.3% of all malignancies in men. We report a 52 ...
Treatment of primary tumour represents one of the main issues in the management of squamous cell car...
Penile Carcinoma is a malignant disease with low incidence. 0,5 - 1,0 case occurs in population of 1...
Squamous penile carcinoma is an uncommon neoplastic disease with an incidence of one in 100 000 men ...
Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. Whi...
Penile tumors are the rarest male urogenital tract tumors (1%). Squamous cell carcinoma is the most ...
Penile carcinoma is a relatively rare disease in the Western world. In this thesis it was shown that...
24 cases of penile carcinoma, occurred from 1970 to 1979, have been examinated. The role of limphoad...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
Although in the western world penile cancer accounts for less than 1% of all male malignancies, it r...
Abstract. Penile tumors represent a difficult group of neoplasms requiring effective and curative tr...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
Abstract: The majority of penile carcinoma is squamous cell carcinoma. Although uncommon in the Unit...
The penile carcinoma is rare neoplasia representing 1.3% of all malignancies in men. We report a 52 ...
Treatment of primary tumour represents one of the main issues in the management of squamous cell car...
Penile Carcinoma is a malignant disease with low incidence. 0,5 - 1,0 case occurs in population of 1...
Squamous penile carcinoma is an uncommon neoplastic disease with an incidence of one in 100 000 men ...
Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. Whi...
Penile tumors are the rarest male urogenital tract tumors (1%). Squamous cell carcinoma is the most ...
Penile carcinoma is a relatively rare disease in the Western world. In this thesis it was shown that...
24 cases of penile carcinoma, occurred from 1970 to 1979, have been examinated. The role of limphoad...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
Although in the western world penile cancer accounts for less than 1% of all male malignancies, it r...
Abstract. Penile tumors represent a difficult group of neoplasms requiring effective and curative tr...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
Abstract: The majority of penile carcinoma is squamous cell carcinoma. Although uncommon in the Unit...
The penile carcinoma is rare neoplasia representing 1.3% of all malignancies in men. We report a 52 ...
Treatment of primary tumour represents one of the main issues in the management of squamous cell car...